Investor Relations

Press Releases

Date Title and Summary Additional Formats
Toggle Summary ELAD® Liver Support System Study Initiated at Multiple U.S. Center
Program Expands on Successful Results from prior U.S., U.K. and China Trials
View HTML
Toggle Summary Vital Therapies™ Announces Presentation of ELAD® "Artificial Liver" Data at American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting.
Boston, MA., Nov. 7, 2007 /PRNewswire/- /- Vital Therapies, Inc. (VTI), announced today data from two studies of the company’s ELAD® (Extracorporeal Liver Assist Device) System were presented at the 2007 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, which
View HTML